Skip to content

OCRA Financial Stewardship

Financial Stewardship

Preserving The Public Trust

Transparency, Accountability, Stewardship

When you donate to OCRA, you can be sure your money is handled responsibly. By ensuring rigorous accountability, financial transparency, and meticulous stewardship of our donors’ funds, OCRA has earned the highest possible rating from Charity Navigator and a Platinum rating from Guidestar. We also meet the stringent Standards for Charity Accountability set forth by the Better Business Bureau’s Wise Giving Alliance.

 

Please explore this page to view our financial statements and policies.

Financial Statements

Ovarian Cancer Research Alliance is a 501(c) 3 non profit organization. Our financial documents are public and available for viewing below.

Financial Statements from Ovarian Cancer Research Alliance:

Financial Statements from the former Ovarian Cancer Research Fund:

Financial Statements from the former Ovarian Cancer National Alliance:

Policies

A 501(c)(3) organization, Ovarian Cancer Research Alliance receives funding from individual donors, foundations, corporations, and cause-marketing initiatives. Individual solicitations, direct mail, fundraising events, grant proposals, sponsorships, product sales, and special projects secure these funds.

Our mission is to remain objective in providing information to the ovarian cancer community; we do not endorse any particular treatment, therapy, clinical trial or product.

Ovarian Cancer Research Alliance is committed to:

  • Ensuring that fundraising complies with all applicable federal and state regulations, including appropriate registrations, annual filings, and audits to comply with the Internal Revenue Code;
  • Providing the public with access to its most recent financial reports and filings;
  • Maintaining the confidentiality of donors’ information and ensuring any disclosures comply with all applicable laws;
  • Accepting contributions from sources such as individuals, foundations, and for-profit institutions while ensuring that the positions of Ovarian Cancer Research Alliance on policy issues are never unduly or improperly influenced by contributors.

Conflict of Interest Statement — Industry Partners

  • Corporate partners including industry do not shape OCRA’s agenda, research, or advocacy.
  • In 2023, industry partners represented 8% of OCRA’s overall revenue.
  • If an industry partner sponsors an OCRA program, grant, or educational materials, it is publicly acknowledged and the supporting company has no editorial or strategic input.
  • Any reference to a specific commercial product or service does not constitute or imply an endorsement by OCRA of the product or service or its producer or provider. The views and opinions expressed in any referenced document or on any referenced website do not necessarily reflect those of OCRA.

Related Topics

The Overview: July 2026

The Overview: July 2026

SummeRun Raises $260,000+ for Research, Hope and Progress Nearly one thousand runners, walkers, survivors, families, friends, and supporters showed up at Seattle’s Seward Park on Sunday, July 12th, for the 33rd annual Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, raising more than $260,000 for research and programs that support the gynecologic cancer community. The … Continued

Read more

Navigating Platinum-Resistant Ovarian Cancer: Everyday Health Shares Coping Strategies and OCRA Resources

Navigating Platinum-Resistant Ovarian Cancer: Everyday Health Shares Coping Strategies and OCRA Resources

In an article published by Everyday Health, “Coping With the Emotional Challenges of Platinum-Resistant Ovarian Cancer” (June 10, 2026), Ovarian Cancer Research Alliance (OCRA) community member Amanda Widro shares her experience navigating a platinum-resistant ovarian cancer diagnosis. Ovarian cancer is considered platinum-resistant when it recurs within six months of finishing platinum-based chemotherapy. Widro, who was … Continued

Read more

OCRA Rivkin Family SummeRun Brings Together Nearly 1,000 Participants for a Day of Hope and Progress for Ovarian Cancer Research

OCRA Rivkin Family SummeRun Brings Together Nearly 1,000 Participants for a Day of Hope and Progress for Ovarian Cancer Research

Nearly 1,000 runners, walkers, survivors, families, friends, and supporters gathered at Seattle’s Seward Park on Sunday, July 12, 2026, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun. This year’s event raised more than $260,000. Now in its 33rd year, the event once again transformed the park into a sea of teal and purple, … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.